About Dermelix

About company

Dermelix is a clinical-stage biopharmaceutical company focused on delivering innovative treatments to patients suffering from rare genetic skin diseases. Our team consists of a small group of drug developers with extensive experience in getting drugs approved in the rare disease space. We are currently developing therapies across multiple innovative therapeutic modalities.